Table 4. Gene expression differences within the DDFT between non-operated control (NOC), transected extensor tendon (TxEXT) and partially transected SDFT (TxSDFT) groups.
Gene | Region | KW (p-value) | NOC vs Tx Ext | MWU (p-value) | NOC vs Tx SDFT | MWU (p-value) |
---|---|---|---|---|---|---|
COL3 | P2 | 0.019 | nd | 0.749 | TxSDFT > NOC; 16.2 fold | 0.016 |
P1 | 0.006 | nd | 0.522 | TxSDFT > NOC; 14.4 fold | 0.007 | |
D1 | 0.010 | nd | 0.522 | TxSDFT > NOC; 49.5 fold | 0.010 | |
D2 | 0.209 | |||||
VCAN | P2 | 0.013 | nd | 0.631 | TxSDFT > NOC; 7.16 fold | 0.007 |
P1 | 0.281 | |||||
D1 | 0.040 | nd | 0.749 | TxSDFT > NOC; 7.10 fold | 0.025 | |
D2 | 0.140 | |||||
BGN | P2 | 0.002 | nd | 0.109 | TxSDFT > NOC; 20.8 fold | 0.004 |
P1 | 0.144 | |||||
D1 | 0.007 | nd | 0.423 | TxSDFT > NOC; 4.71 fold | 0.016 | |
D2 | 0.130 | |||||
LUM | P2 | 0.004 | nd | 0.337 | TxSDFT > NOC; 142 fold | 0.004 |
P1 | 0.002 | nd | 0.150 | TxSDFT > NOC; 131 fold | 0.004 | |
D1 | 0.003 | nd | 0.873 | TxSDFT > NOC; 190 fold | 0.004 | |
D2 | 0.003 | nd | 0.522 | TxSDFT > NOC; 33.9 fold | 0.004 | |
MMP-1 | P2 | 0.203 | ||||
P1 | 0.039 | nd | 0.631 | TxSDFT > NOC; 4.69 fold | 0.037 | |
D1 | 0.249 | |||||
D2 | 0.402 | |||||
ADAMTS4 | P2 | 0.097 | ||||
P1 | 0.386 | |||||
D1 | 0.220 | |||||
D2 | 0.250 |
Mean fold changes for each region were calculated by dividing the relative fluorescent unit (RFU) value of the TxEXT and TxSDFT groups by the mean RFU of each region of the NOC group. P values are presented for each comparison. KW = Kruskal-Wallis analysis; MWU = Mann-Whitney U analysis; NOC = non-operated control; TxEXT = completely transected extensor tendons; TxSDFT = partially transected superficial digital flexor tendon (SDFT); nd = no difference. The column for ‘Region’ refers to the regions sampled as per Fig 2; with P2 being closest to the carpus and D2 being closest to the metacarpophalangeal joint. The level of transection in either the extensor tendons or SDFT would lie between P1 and D1.